Medical Review Institute of America, LLC

Medical Review Institute of America, LLC provides evidence-based clinical reviews to enhance healthcare quality and efficiency, focusing on independent utilization management and peer-to-peer consultations through a nationwide network of licensed professionals. Founded in 1983 and headquartered in Salt Lake City, US, Medical Review Institute of America specializes in clinical reviews in healthcare. The company has made strategic adjustments to its operations, adapting to industry demands while maintaining focus on its core services. The current CEO, Ron Sullivan, leads the firm as it continues to evolve in a competitive landscape.

The company has engaged in 3 notable deals, with the most recent occurring on July 8, 2024. MRIoA specializes in evidence-based clinical reviews aimed at enhancing the quality and efficiency of healthcare services. The company offers a suite of solutions that include independent utilization management reviews, prior authorization assessments, specialty drug reviews, and peer-to-peer consultations conducted by a nationwide network of licensed healthcare professionals, including physicians, nurses, and pharmacists. These services ensure that medical care is appropriate and cost-effective, addressing issues like unnecessary costs while enhancing clinical decision-making.

MRIoA serves healthcare organizations, government agencies, managed care plans, self-insured employers, and unions across the United States, supported by advanced analytics and benchmarking data that improve patient outcomes. MRIoA generates revenue through a structured business model that primarily involves B2B transactions with healthcare entities. Clients engage MRIoA's services through contractual agreements, typically involving subscriptions for ongoing clinical review services and one-time assessments. The pricing structure reflects the complexity and urgency of the reviews, tailored to client needs.

Major healthcare providers, managed care organizations, and government agencies rely on MRIoA for actionable insights that enhance care quality and reduce administrative burdens, fostering long-term partnerships. Following a recent investment by Parthenon Capital on July 8, 2024, which included a reinvestment from Summit Partners, MRIoA plans to utilize the funding to support service and platform enhancements as well as business expansion. The company aims to develop new products to improve its offerings and seeks to expand into new markets, although specific regions have not been detailed. The focus will likely be on enhancing its technological capabilities and service delivery mechanisms to better serve its clientele.